ArticleOncotarget2016

Imatinib and polypharmacy in very old patients with chronic myeloid leukemia: effects on response rate, toxicity and outcome.

Alessandra Iurlo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.